Nihal Ahmad - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Oncology, Cell Biology

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Denu RA, Shabbir M, Nihal M, Singh CK, Longley BJ, Burkard ME, Ahmad N. Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma. Molecular Cancer Research : McR. PMID 29330283 DOI: 10.1158/1541-7786.MCR-17-0197  0.4
2016 Singh CK, Malas KM, Tydrick C, Siddiqui IA, Iczkowski KA, Ahmad N. Analysis of Zinc-Exporters Expression in Prostate Cancer. Scientific Reports. 6: 36772. PMID 27833104 DOI: 10.1038/srep36772  0.36
2016 Singh CK, Nihal M, Ahmad N. Histone Deacetylase Inhibitory Approaches for the Management of Osteoarthritis. The American Journal of Pathology. PMID 27560709 DOI: 10.1016/j.ajpath.2016.08.001  0.4
2016 Singh CK, Siddiqui IA, El-Abd S, Mukhtar H, Ahmad N. Combination chemoprevention with grape antioxidants. Molecular Nutrition & Food Research. PMID 26829056 DOI: 10.1002/mnfr.201500945  0.44
2015 George J, Nihal M, Singh CK, Zhong W, Liu X, Ahmad N. Pro-proliferative function of mitochondrial sirtuin deacetylase SIRT3 in human melanoma. The Journal of Investigative Dermatology. PMID 26743598 DOI: 10.1016/j.jid.2015.12.026  0.4
2015 Siddiqui IA, Sanna V, Ahmad N, Sechi M, Mukhtar H. Resveratrol nanoformulation for cancer prevention and therapy. Annals of the New York Academy of Sciences. 1348: 20-31. PMID 26109073 DOI: 10.1111/nyas.12811  0.44
2015 Singh CK, Kaur S, George J, Nihal M, Pellitteri Hahn MC, Scarlett CO, Ahmad N. Molecular signatures of sanguinarine in human pancreatic cancer cells: A large scale label-free comparative proteomics approach. Oncotarget. 6: 10335-48. PMID 25929337  0.4
2014 Wilking MJ, Singh CK, Nihal M, Ndiaye MA, Ahmad N. Sirtuin deacetylases: a new target for melanoma management. Cell Cycle (Georgetown, Tex.). 13: 2821-6. PMID 25486469 DOI: 10.4161/15384101.2014.949085  0.4
2014 Singh CK, Ndiaye MA, Siddiqui IA, Nihal M, Havighurst T, Kim K, Zhong W, Mukhtar H, Ahmad N. Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model. Oncotarget. 5: 3651-61. PMID 25004451  0.44
2014 Wilking MJ, Singh C, Nihal M, Zhong W, Ahmad N. SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation. Archives of Biochemistry and Biophysics. 563: 94-100. PMID 24751483 DOI: 10.1016/j.abb.2014.04.001  0.4
2014 Singh CK, George J, Nihal M, Sabat G, Kumar R, Ahmad N. Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach. Oncotarget. 5: 1987-99. PMID 24743044  0.44
2014 Nihal M, Ahmad N, Wood GS. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Cell Cycle (Georgetown, Tex.). 13: 632-40. PMID 24343700 DOI: 10.4161/cc.27523  0.4
2014 Ndiaye MA, Nihal M, Wood GS, Ahmad N. Skin, reactive oxygen species, and circadian clocks. Antioxidants & Redox Signaling. 20: 2982-96. PMID 24111846 DOI: 10.1089/ars.2013.5645  0.4
2013 Ahmad N, Mukhtar H. Antioxidants meet molecular targets for cancer prevention and therapeutics. Antioxidants & Redox Signaling. 19: 85-8. PMID 23521502 DOI: 10.1089/ars.2013.5299  0.44
2013 Wilking M, Ndiaye M, Mukhtar H, Ahmad N. Circadian rhythm connections to oxidative stress: Implications for human health Antioxidants and Redox Signaling. 19: 192-208. PMID 23198849 DOI: 10.1089/ars.2012.4889  0.44
2013 Khan N, Syed DN, Ahmad N, Mukhtar H. Fisetin: a dietary antioxidant for health promotion. Antioxidants & Redox Signaling. 19: 151-62. PMID 23121441 DOI: 10.1089/ars.2012.4901  0.44
2012 Schmit TL, Nihal M, Ndiaye M, Setaluri V, Spiegelman VS, Ahmad N. Numb regulates stability and localization of the mitotic kinase PLK1 and is required for transit through mitosis. Cancer Research. 72: 3864-72. PMID 22593191 DOI: 10.1158/0008-5472.CAN-12-0714  1
2011 Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, Ahmad N. Enhancing the bioavailability of resveratrol by combining it with piperine. Molecular Nutrition & Food Research. 55: 1169-76. PMID 21714124 DOI: 10.1002/mnfr.201100117  0.44
2011 Khan SH, Ahmad F, Ahmad N, Flynn DC, Kumar R. Protein-protein interactions: principles, techniques, and their potential role in new drug development. Journal of Biomolecular Structure & Dynamics. 28: 929-38. PMID 21469753 DOI: 10.1080/07391102.2011.10508619  0.44
2011 Nihal M, Stutz N, Schmit T, Ahmad N, Wood GS. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis. Cell Cycle (Georgetown, Tex.). 10: 1303-11. PMID 21436619  0.4
2011 Ndiaye M, Kumar R, Ahmad N. Resveratrol in cancer management: where are we and where we go from here? Annals of the New York Academy of Sciences. 1215: 144-9. PMID 21261653 DOI: 10.1111/j.1749-6632.2010.05851.x  0.44
2011 Ndiaye M, Philippe C, Mukhtar H, Ahmad N. The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges. Archives of Biochemistry and Biophysics. 508: 164-70. PMID 21215251 DOI: 10.1016/j.abb.2010.12.030  0.44
2011 Jung-Hynes B, Schmit TL, Reagan-Shaw SR, Siddiqui IA, Mukhtar H, Ahmad N. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. Journal of Pineal Research. 50: 140-9. PMID 21062352 DOI: 10.1111/j.1600-079X.2010.00823.x  1
2011 Ahmad N, Kumar R. Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Letters. 300: 1-9. PMID 20926181 DOI: 10.1016/j.canlet.2010.09.008  0.44
2011 Ledesma MC, Jung-Hynes B, Schmit TL, Kumar R, Mukhtar H, Ahmad N. Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status. Molecular Medicine (Cambridge, Mass.). 17: 134-43. PMID 20882260 DOI: 10.2119/molmed.2010.00136  1
2010 Khan SH, Ahmad N, Ahmad F, Kumar R. Naturally occurring organic osmolytes: from cell physiology to disease prevention. Iubmb Life. 62: 891-5. PMID 21190292 DOI: 10.1002/iub.406  0.44
2010 Siddiqui IA, Adhami VM, Ahmad N, Mukhtar H. Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutrition and Cancer. 62: 883-90. PMID 20924964 DOI: 10.1080/01635581.2010.509537  0.44
2010 Jung-Hynes B, Huang W, Reiter RJ, Ahmad N. Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. Journal of Pineal Research. 49: 60-8. PMID 20524973 DOI: 10.1111/j.1600-079X.2010.00767.x  0.44
2010 Reagan-Shaw S, Eggert D, Mukhtar H, Ahmad N. Antiproliferative effects of apple peel extract against cancer cells. Nutrition and Cancer. 62: 517-24. PMID 20432173 DOI: 10.1080/01635580903441253  0.44
2010 Schmit TL, Ledesma MC, Ahmad N. Modulating polo-like kinase 1 as a means for cancer chemoprevention. Pharmaceutical Research. 27: 989-98. PMID 20107874 DOI: 10.1007/s11095-010-0051-8  1
2010 Jung-Hynes B, Reiter RJ, Ahmad N. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. Journal of Pineal Research. 48: 9-19. PMID 20025641 DOI: 10.1111/j.1600-079X.2009.00729.x  0.44
2009 Schmit TL, Zhong W, Nihal M, Ahmad N. Polo-like kinase 1 (Plk1) in non-melanoma skin cancers. Cell Cycle (Georgetown, Tex.). 8: 2697-702. PMID 19652546 DOI: 10.4161/cc.8.17.9413  1
2009 Schmit TL, Zhong W, Setaluri V, Spiegelman VS, Ahmad N. Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells. The Journal of Investigative Dermatology. 129: 2843-53. PMID 19554017 DOI: 10.1038/jid.2009.172  1
2009 Nihal M, Ahsan H, Siddiqui IA, Mukhtar H, Ahmad N, Wood GS. (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma. Cell Cycle (Georgetown, Tex.). 8: 2057-63. PMID 19502799  0.44
2009 Jung-Hynes B, Ahmad N. SIRT1 controls circadian clock circuitry and promotes cell survival: a connection with age-related neoplasms. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2803-9. PMID 19439501 DOI: 10.1096/fj.09-129148  0.44
2009 Jung-Hynes B, Ahmad N. Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells. Cell Cycle (Georgetown, Tex.). 8: 1478-83. PMID 19377286 DOI: 10.4161/cc.8.10.8408  0.44
2009 Adhami VM, Siddiqui IA, Sarfaraz S, Khwaja SI, Hafeez BB, Ahmad N, Mukhtar H. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1947-53. PMID 19276266 DOI: 10.1158/1078-0432.CCR-08-2332  0.44
2009 Siddiqui IA, Adhami VM, Bharali DJ, Hafeez BB, Asim M, Khwaja SI, Ahmad N, Cui H, Mousa SA, Mukhtar H. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Research. 69: 1712-6. PMID 19223530 DOI: 10.1158/0008-5472.CAN-08-3978  0.44
2009 Garza AS, Ahmad N, Kumar R. Role of intrinsically disordered protein regions/domains in transcriptional regulation. Life Sciences. 84: 189-93. PMID 19109982 DOI: 10.1016/j.lfs.2008.12.002  0.44
2009 Jung-Hynes B, Nihal M, Zhong W, Ahmad N. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition? The Journal of Biological Chemistry. 284: 3823-32. PMID 19075016 DOI: 10.1074/jbc.M807869200  0.44
2008 Reagan-Shaw S, Nihal M, Ahsan H, Mukhtar H, Ahmad N. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio Prostate. 68: 1624-1634. PMID 18668529 DOI: 10.1002/pros.20824  0.44
2008 Reagan-Shaw S, Mukhtar H, Ahmad N. Resveratrol imparts photoprotection of normal cells and enhances the efficacy of radiation therapy in cancer cells. Photochemistry and Photobiology. 84: 415-21. PMID 18221451 DOI: 10.1111/j.1751-1097.2007.00279.x  0.44
2008 Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 659-61. PMID 17942826 DOI: 10.1096/fj.07-9574LSF  0.4
2007 Ahsan H, Reagan-Shaw S, Eggert DM, Tan TC, Afaq F, Mukhtar H, Ahmad N. Protective effect of sanguinarine on ultraviolet B-mediated damages in SKH-1 hairless mouse skin: implications for prevention of skin cancer. Photochemistry and Photobiology. 83: 986-93. PMID 17645675 DOI: 10.1111/j.1751-1097.2007.00156.x  0.44
2007 Schmit TL, Ahmad N. Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Molecular Cancer Therapeutics. 6: 1920-31. PMID 17620424 DOI: 10.1158/1535-7163.MCT-06-0781  1
2006 Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Molecular Cancer Therapeutics. 5: 1335-41. PMID 16731767 DOI: 10.1158/1535-7163.MCT-05-0526  0.4
2006 Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Research. 66: 2500-5. PMID 16510563 DOI: 10.1158/0008-5472.CAN-05-3636  0.44
2006 Siddiqui IA, Zaman N, Aziz MH, Reagan-Shaw SR, Sarfaraz S, Adhami VM, Ahmad N, Raisuddin S, Mukhtar H. Inhibition of CWR22Rν1 tumor growth and PSA secretion in athymic nude mice by green and black teas Carcinogenesis. 27: 833-839. PMID 16387739 DOI: 10.1093/carcin/bgi323  0.44
2005 Saleem M, Adhami VM, Ahmad N, Gupta S, Mukhtar H. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 147-53. PMID 15671539  0.44
2005 Nihal M, Ahmad N, Mukhtar H, Wood GS. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. International Journal of Cancer. Journal International Du Cancer. 114: 513-21. PMID 15609335 DOI: 10.1002/ijc.20785  0.44
2004 Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Research. 64: 8715-22. PMID 15574782 DOI: 10.1158/0008-5472.CAN-04-2840  0.44
2004 Ahmad N, Mukhtar H. Cytochrome p450: a target for drug development for skin diseases. The Journal of Investigative Dermatology. 123: 417-25. PMID 15304077 DOI: 10.1111/j.0022-202X.2004.23307.x  0.44
2004 Adhami VM, Aziz MH, Reagan-Shaw SR, Nihal M, Mukhtar H, Ahmad N. Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Molecular Cancer Therapeutics. 3: 933-40. PMID 15299076  0.44
2004 Siddiqui IA, Afaq F, Adhami VM, Ahmad N, Mukhtar H. Antioxidants of the beverage tea in promotion of human health. Antioxidants & Redox Signaling. 6: 571-82. PMID 15130283 DOI: 10.1089/152308604773934323  0.44
2004 Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. Journal of Cellular Biochemistry. 91: 232-42. PMID 14743383 DOI: 10.1002/jcb.10737  0.44
2004 Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene. 23: 2507-22. PMID 14676829 DOI: 10.1038/sj.onc.1207353  0.44
2003 Afaq F, Ahmad N, Mukhtar H. Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene. 22: 9254-64. PMID 14681684 DOI: 10.1038/sj.onc.1207035  0.44
2003 Adhami VM, Aziz MH, Mukhtar H, Ahmad N. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 3176-82. PMID 12912970  0.44
2003 Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene. 22: 4851-9. PMID 12894226 DOI: 10.1038/sj.onc.1206708  0.44
2003 Adhami VM, Ahmad N, Mukhtar H. Molecular targets for green tea in prostate cancer prevention. The Journal of Nutrition. 133: 2417S-2424S. PMID 12840218  0.44
2003 Aziz MH, Kumar R, Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). International Journal of Oncology. 23: 17-28. PMID 12792772  0.44
2003 Afaq F, Adhami VM, Ahmad N, Mukhtar H. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene. 22: 1035-44. PMID 12592390 DOI: 10.1038/sj.onc.1206206  0.44
2002 Afaq F, Adhami VM, Ahmad N, Mukhtar H. Botanical antioxidants for chemoprevention of photocarcinogenesis. Frontiers in Bioscience : a Journal and Virtual Library. 7: d784-92. PMID 11897547  0.44
2002 Ahmad N, Adhami VM, Gupta S, Cheng P, Mukhtar H. Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate. Archives of Biochemistry and Biophysics. 398: 125-31. PMID 11811957 DOI: 10.1006/abbi.2001.2704  0.44
Show low-probability matches.